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Maurocalcine is a 33-mer peptide 
initially isolated from the venom of a Tunisian 
scorpion. It has proved itself valuable as a 
pharmacological activator of the ryanodine 
receptor, and has helped the understanding the 
molecular basis underlying excitation-
contraction coupling in skeletal muscles. 
Because of its positively charged nature, it is 
also an innovative vector for the cell 
penetration of various compounds. We report a 
novel maurocalcine analog with improved 
properties: (i) the complete loss of 
pharmacological activity, (ii) preservation of the 
potent ability to carry cargo molecules into 
cells, and (iii) with coupling chemistries not 
affected by the presence of internal cysteine 
residues of maurocalcine. We did this by 
replacing the six internal cysteine residues of 
maurocalcine by isosteric 2-aminobutyric acid 
residues and by adding an additional N-
terminal biotinylated lysine (for a proof of 
concept analog) or an N-terminal cysteine 
residue (for a chemically-competent coupling 
analogue). Additional replacement of a 
glutamate residue by alanyl at position 12 
further improves the potency of these 
analogues. Coupling to several cargo molecules 
or nanoparticles are presented to illustrate the 
cell penetration potency and usefulness of these 
pharmacologically inactive analogs. 
 Maurocalcine (MCa) is a highly basic 33-
mer peptide isolated from the venom of the 
scorpion Scorpio maurus palmatus. It efficiently 
binds to the ryanodine receptor in skeletal muscles 
(RyR1 isoform) (1) and promotes channel opening 
to promote calcium release from the sarcoplasmic 
reticulum (SR). This pharmacological effect of 
MCa can be indirectly monitored through the 
stimulation it exerts on [3H]-ryanodine binding (2). 
In muscle fibers, MCa produces a transient loss of 
voltage control of Ca2+ release from RyR1 
channels. This effect is due to an alteration of 
repolarization-induced closure of RyR1 channels, a 
process normally under the control of voltage-
dependent dihydropyridine (DHP)-sensitive 
calcium channels (3). This function of MCa is due 
to a partial sequence homology between MCa and 
a cytoplasmic loop of the DHP-sensitive channel 
(2). These observations explain why MCa, along 
with other members of the same family of toxins 
such as imperatoxin 1A (4), hemicalcin (5), and 
opicalcin 1 and 2 (6), are useful both for their 
pharmacological properties and for deciphering 
fine molecular details of the excitation-contraction 
coupling process. 
Recently, MCa has also proven of interest 
for its property of efficiently crossing the plasma 
membrane, either alone or when coupled to a 
membrane-impermeant cargo protein (2,7). MCa is 
a highly charged peptide with 12 basic residues out 
of 33, and a net global positive charge of +8. Most 
of these residues are on one face of the molecule, 
the opposite face being mostly hydrophobic in 
nature. The rich content in basic amino acid 
residues of MCa is reminiscent of that of all cell 
penetrating peptides (CPPs) characterized so far 
(Tat, penetratin and poly-R). Hence, MCa can be 
classified within an emerging family of toxin CPPs 
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that have no structural homologies apart from their 
content in basic residues. Recently, a new toxin, 
crotamin, has been purified from the venom of a 
South American snake. It also behaves as a CPP 
but apparently with a preference for dividing cells 
(8). The great diversity in CPP sequences observed 
so far suggests that designing new MCa CPP 
analogues should be easy. This tolerance in 
sequence variation is possibly due to the diverse 
nature of membrane receptors implicated in CPP 
cell translocation. These receptors nevertheless 
possess a single point in common: they all appear 
to interact with CPPs on the basis of electrostatic 
interactions. On the contrary, the structural 
characteristics of the interaction between MCa and 
RyR1 appear far more constrained. A single 
mutation within MCa, the replacement of an Arg 
residue by an alanyl, abolishes the 
pharmacological effect of MCa but has only mild 
effects on its cell penetration efficacy (9). 
Nevertheless, segregating the pharmacological 
properties from the cell penetrating properties 
proved more complex than expected on the sole 
basis of amino acid substitutions of MCa (9). This 
appears to be due to structural imperatives of the 
molecule since it has four functions to fulfill: first, 
possess the attributes of a CPP, second, conserve 
sequence homology with the DHP-sensitive 
calcium channel, third, bind to RyR1 and fourth, 
activate this latter channel. Many residues 
contribute both to the pharmacological effects and 
the cell penetration properties, namely some basic 
residues that make the functional segregation 
difficult with simple amino acid substitutions.  
 To both circumvent these difficulties and 
take advantage of the flexibility in structural 
constraints required for MCa cell penetration, we 
sought a novel strategy for the design of an MCa 
analogue that would lose its pharmacological 
activity while retaining most of its cell penetration 
efficacy. As determined by 1H-NMR, MCa folds 
along an inhibitor cystine knot motif with a 
disulfide bridge pattern of Cys3–Cys17, Cys10–
Cys21, and Cys16–Cys32. It contains three β-strands 
that run from amino acid residues 9–11 (strand 1), 
20–23 (strand 2), and 30–33 (strand 3), with β-
strands 2 and 3 forming an antiparallel β-sheet 
(10). In earlier studies on another toxin, 
maurotoxin (MTX), active on voltage-gated 
potassium channels, it was found that the disulfide 
bridges of the peptide play an essential role in the 
three-dimensional structure of the toxin and thus 
on its activity (11). We therefore adopted a similar 
strategy for the design of a novel analogue of MCa 
in which we replaced all native cysteine residues, 
engaged in the three disulfide bridges, by isosteric 
2-aminobutyric acid residues. The goal was to 
obtain a structurally-altered analogue displaying a 
complete loss of pharmacological activity but 
preserving the positively charged nature of the 
peptide, a property required for the efficient cell 
penetration of a CPP. To further validate this 
analogue, three derivatives were produced that 
comprise either an N-terminal biotinylated lysine 
residue with or without an alanyl substitution of 
Glu12, previously shown to favor cell penetration 
(9), or an N-terminal cysteine residue for coupling 
chemistries to various cargoes. This chemical 
synthesis was accompanied by pharmacological 
assays, toxicity experiments, and proof of concept 
that cargo penetration is fully conserved. The data 
indicate that cysteine replacement within MCa can 
produce potent cell-penetrating analogues of MCa 
devoid of pharmacological activity. 
 
Experimental Procedures 
 
Reagents – Streptavidin-Cy5 (Strep-Cy5) was from 
Amersham Biosciences (USA), dihydroethidium 
(DHE) from Molecular Probes (USA), and 
rhodamine- and FITC-conjugated concanavalin A 
were from AbCys and Sigma, respectively. 
Doxorubicin was from Alexis Biochemicals 
(USA). The TK705-amino-(polyethyleneglycol) 
quantum dots (QD) with surface activated amine 
groups were purchased from InVitrogen. [3H]-
ryanodine was from Perkin-Elmer (USA). 
Peptide synthesis - MCab was synthesized as 
previously described (7). MCab-Abu, MCab-Abu 
E12A and FITC-Gpep-Cys were purchased from 
the Department of Pharmaceutical Sciences, 
University of Ferrara (Italy). Cys-MCa-Abu was 
synthesized by NeoMPS (France). MTXb-Abu was 
assembled by the group of Dr. JM Sabatier 
(France). 
Formation of MCab/, MCab-Abu/, MCab-Abu 
E12A/, or MTXb-Abu/Strep-Cy5 complexes – 
Soluble Strep-Cy5 was mixed with four molar 
equivalents of MCab, MCab-Abu, MCab-Abu E12A 
or MTXb-Abu for 2 hrs at 37°C in the dark in 
phosphate-buffered saline (PBS, in mM: NaCl 136, 
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Na2HPO4 4.3, KH2PO4 1.47, KCl 2.6, CaCl2 1, 
MgCl2 0.5, pH 7.2). 
Conjugation of Cys-MCa-Abu to various cargoes – 
Cys-MCa-Abu was conjugated to a FITC-Gpep-
Cys molecule (sequence derived from Gβ1: FITC-
beta-AGITSVAFSRSGRLLLAGYDDFN-Abu-
NIWDAMKGDRAC-OH) according to the 
method used by Davidson et al. (12). Briefly, an 
equimolar mixture of Cys-MCa-Abu and FITC-
Gpep-Cys was heated to 65°C for 15 min and then 
incubated at 37°C for 1 hr. The complex was 
purified by fast protein liquid chromatography. 
Cys-MCa-Abu was also conjugated to 
doxorubicin. Briefly, doxorubicin.HCl (1 mg/ml) 
was suspended in PBS pH 8.0 and conjugated to 
Cys-MCa-Abu using succinimidyl-4-(N-
maleimidomethyl) cyclohexane-1-carboxylate 
(Pierce) according to the protocol of Liang et al. 
(13). Successful coupling was followed by a 
16.5% SDS-PAGE and UV detection of the 
resulting conjugated doxorubicin-linker-Cys-MCa-
Abu peptide. 
QD were also conjugated to Cys-MCa-Abu. The 
amino groups of the QD (≈ 100 to 120 functions 
per particle) were first converted into a maleimide 
coating as described (14), thereby yielding QDM. 
Briefly, QD (1 nmol) were incubated for 4 hrs in 
the dark at room temperature in PBS in the 
presence of 4-maleimidobutyric acid N-
hydrosuccinimide ester (1.8 µmol, in anhydrous 
dimethylsulfoxide (DMSO)), then purified using 
NAP-5 columns (Amersham Biosciences). 20 µL 
of tris-(2-carboxyethyl)phosphine hydrochloride 
solution 0.5 M was added to 100 nmol of the Cys-
MCa-Abu in 80 µL of water for 30 min, and then 
incubated overnight at room temperature with 
QDM  in the presence of 1 mM EDTA pH 7.4. 
Non-reacted maleimide groups were quenched for 
20 min by adding 2-mercapthoethanol in excess 
(500 nmol). The QDM-Cys-MCa-Abu conjugates 
were purified using NAP-5 columns (Amersham 
Biosciences). Surface modifications of QD were 
detected by 1% agarose gel electrophoresis in a 
TAE buffer pH 8, and imaged by fluorescence 
using a 633 nm excitation wavelength and 
collecting emitted light above 700 nm. The 
hydrodynamic diameter of the QDM-Cys-MCa-
Abu nanoparticles measured using a Zetasizer 
Nano (Malvern Instruments) were 25 nm in PBS 
(20.5 nm for non-modified QD). The QDM-Cys-
MCa-Abu concentration was calculated using 532 
nm absorbance measurements (QD molar 
extinction coefficient ε = 2.1 × 106 M-1 cm-1 at 532 
nm). 
Cell culture – Wild-type Chinese Hamster Ovary 
(CHO-K1) cells (from ATCC) were maintained at 
37°C in 5% CO2 in F-12K nutrient medium 
(Invitrogen) supplemented with 10% (v/v) heat-
inactivated fetal bovine serum (InVitrogen) and 
10,000 units/ml streptomycin and penicillin 
(Invitrogen). MDA-MB-231 cells from ATCC 
were grown in Leibovitz L15 medium 
supplemented with 10% (v/v) heat-inactivated fetal 
bovine serum and 10,000 units/ml streptomycin 
and penicillin. Media used for the culture of 
cerebellar granule neurons was based on 
Dulbecco's modified Eagle's medium (DMEM, 
Invitrogen) containing 10 unit/ml penicillin, 10 
µg/ml streptomycin, 2 mM L-glutamine, and 10 
mM HEPES, 25 mM KCl and 10% fetal bovine 
serum. Primary cultures were prepared from 6-day-
old S/IOPS NMRI mice (Charles River 
Laboratories), as described previously (15). 
Preparation of heavy SR vesicles - Heavy SR 
vesicles were prepared following the method of 
Kim et al. (16). Protein concentration was 
measured by the Biuret method. 
Isolation and preparation of flexor digitorum 
brevis muscle fibers – Experiments were 
performed on single skeletal fibers isolated from 
the flexor digitorum brevis (FDB) muscles from 4- 
to 8-week old OF1 mice (Charles River 
Laboratories, France) in accordance with the 
guidelines of the French Ministry of Agriculture 
(87/848) and of the European Community 
(86/609/EEC). Procedures for enzymatic isolation 
of single fibers and partial insulation of the fibers 
with silicone grease were as previously described 
(17,18). In brief, mice were killed by cervical 
dislocation after halothane (Sigma-Aldrich, 
France) inhalation before removal of the muscles. 
Muscles were treated with 2 mg/ml collagenase 
type I (Sigma-Aldrich) in Tyrode solution for 60 
min at 37°C. Single fibers were then isolated by 
triturating the muscles in the experimental 
chamber. The major part of a single fiber was 
electrically insulated with silicone grease (Rhodia 
Siliconi Italia, Treviolo, Italia) so that whole-cell 
voltage-clamp could be achieved on a short portion 
of the fiber extremity. All experiments were 
performed at room temperature (20-22°C). 
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Structural analyses of MCab, MCab-Abu, MCab-
Abu E12A by circular dichroism – Circular 
dichroism (CD) spectra were recorded on a Jasco 
810 dichrograph using 1 mm-thick quartz cells. 
Spectra were recorded between 180 and 260 nm at 
0.2 nm/min and were averaged from three 
independent acquisitions. The spectra were 
corrected for water signal and smoothed by using a 
third-order least squares polynomial fit. 
[3H]-ryanodine binding assay – Heavy SR vesicles 
(1 mg/ml) were incubated at 37°C for 3 hrs in an 
assay buffer composed of 5 nM [3H]-ryanodine, 
150 mM NaCl, 2 mM EGTA, 2 mM CaCl2 
(pCa=5), and 20 mM HEPES, pH 7.4. 1 µM MCab, 
MCab-Abu or MCab-Abu E12A was added to the 
assay buffer just prior to the addition of heavy SR 
vesicles. [3H]-ryanodine bound to heavy SR 
vesicles was measured by filtration through 
Whatmann GF/B glass filters followed by three 
washes with 5 ml of ice-cold washing buffer 
composed of 150 mM NaCl, 20 mM HEPES, pH 
7.4. Filters were then soaked overnight in 10 ml 
scintillation cocktail (Cybscint, ICN) and bound 
radioactivity determined by scintillation 
spectrometry. Non-specific binding was measured 
in the presence of 20 µM cold ryanodine. Each 
experiment was performed in triplicate and 
repeated three times. All data are presented as 
mean ± S.D. 
Fluorescent measurements under voltage-clamp 
conditions – An RK400 patch-clamp amplifier 
(BioLogic, France) was used in whole-cell 
configuration as previously described (18). 
Voltage-clamp was performed with a 
microelectrode filled with the intracellular-like 
solution (in mM: 120 K glutamate, 5 Na2-ATP, 5 
Na2-phosphocreatine, 5.5 MgCl2, 5 D-glucose, 5 
HEPES adjusted to pH 7.2 with KOH). Indo-1 
(Molecular Probes, USA) was present in this 
solution at 0.2 mM for fluorescence measurements 
under voltage-clamp conditions. The extracellular 
solution contained (in mM): 140 TEA-
methanesulphonate, 2.5 CaCl2, 2 MgCl2, 0.002 
tetrodotoxin, 10 HEPES, pH 7.2. The tip of the 
microelectrode was inserted through the silicon, 
within the insulated part of the fiber. Membrane 
depolarizations were applied every 30 s from a 
holding command potential of -80 mV. For the 
present set of measurements, the cytoplasm was 
dialyzed with the microelectrode solution which 
contained the calcium dye Indo-1 and a given 
peptide to be tested (200 µM for MCab-Abu and 
MCab-Abu E12A, and 100 µM for MCab). In order 
to facilitate intracellular dialysis, the electrode tip 
was broken within the silicon-insulated portion of 
the fiber by pushing it back and forth a few times 
towards the bottom of the chamber. Under these 
conditions, intracellular equilibration of the 
solution was awaited for 30 min. Equilibration was 
followed from the time course of increase of indo-
1 fluorescence in the tested portion of the fiber. 
Indo-1 fluorescence was measured on an inverted 
Nikon Diaphot epifluorescence microscope 
equipped with a commercial optical system 
allowing the simultaneous detection of 
fluorescence at 405 nm (F405) and 485 nm (F485) by 
two photomultipliers (IonOptix, Milton, MA) upon 
360 nm excitation. Background fluorescence at 
both emission wavelengths was measured next to 
each fiber tested and was then subtracted from all 
measurements. In an earlier study, we showed that 
10-100 µM levels of MCa were necessary to affect 
voltage-activated Ca2+ release in intact mammalian 
skeletal muscle fibers (3). For this reason, and 
despite the cell penetration properties of MCa and 
of its derivatives, it is easier and less costly to 
apply these compounds intracellularly through the 
voltage-clamp electrode rather than in the 
extracellular medium. 
Calibration of the Indo-1 response and [Ca2+]intra 
calculation – The standard ratio method was used 
with the parameters: R = F405 / F485, with Rmin, 
Rmax, KD and β having their usual definitions. 
Results were either expressed in terms of Indo-1 
percent saturation or in actual free calcium 
concentration (18,19). In vivo values for Rmin, Rmax 
and β were measured using procedures previously 
described (17). No correction was made for Indo-1 
Ca2+ binding and dissociation kinetics. 
MTT assay - Primary cultures of cerebellar granule 
neurons were seeded into 96 well micro plates at a 
density of approximately 8 × 104 cells/well. After 4 
days of culture, the cells were incubated for 24 hrs 
at 37°C with 10 µM MCab, MCab-Abu, Cys-MCa-
Abu or MCab E12A-Abu. Control wells containing 
cell culture medium alone or with cells, both 
without peptide addition, were included in each 
experiment. The cells were then incubated with 3-
(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-
tetrazolium bromide (MTT) for 30 min. 
Conversion of MTT into purple colored MTT 
formazan by the living cells indicates the degree of 
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cell viability. The crystals were dissolved in 
DMSO and the optical density was measured at 
540 nm using a microplate reader (Biotek ELx-
800, Mandel Scientific Inc.) for quantification of 
cell viability. All assays were run in triplicate. 
Flow cytometry – MCab/, MCab-Abu/, MCab-Abu 
E12A or MTXb-Abu/Strep-Cy5 complexes were 
incubated for 2 hrs with CHO cells to allow cell 
penetration. Control condition was represented by 
an incubation of cells with Strep-Cy5 alone. The 
cells were then washed twice with PBS to remove 
the excess extracellular complexes. Next, the cells 
were treated with 1 mg/ml trypsin (Invitrogen) for 
10 min at 37°C to remove remaining membrane-
associated extracellular cell surface-bound 
complexes. Cell suspension was centrifuged at 
500 g and resuspended in PBS. Flow cytometry 
analyses were performed with live cells using a 
Becton Dickinson FACSCalibur flow cytometer 
(BD Biosciences). Data were obtained and 
analyzed using CellQuest software (BD 
Biosciences). Live cells were gated by 
forward/side scattering from a total of 10,000 
events. Mean fluorescence values were determined 
from Gaussian fits of the resulting histograms and 
plotted as a function of complex concentration.  
Mean values of intracellular fluorescence for 
Strep-Cy5 alone incubation (less than 1% of the 
fluorescence observed for the lowest concentration 
of any of the various MCa / Strep-Cy5 complexes) 
were also subtracted. 
Analysis of the subcellular localization of various 
MCa / or MTX/ cargo complexes by confocal 
microscopy – For Strep-Cy5 complexes, 4 µM of 
MCab, MCab-Abu, MCab-Abu E12A or MTXb-Abu 
were coupled to 1 µM Strep-Cy5 as described 
above. CHO cells were incubated with the 
resulting complexes for 2 hrs, and then washed 
with DMEM alone. Immediately after washing, the 
nucleus was stained with 1 µg/ml DHE for 20 min, 
and then washed again with DMEM. After this 
step, the plasma membrane was stained with 
5 μg/ml of FITC-conjugated concanavalin A for 3 
min. Cells were washed once more, but with PBS. 
For the FITC-Gpep-Cys-Cys-MCa-Abu complex, 
1 µM of the conjugate was incubated with CHO 
cells for 2 hrs, the plasma membrane stained with 
5 μg/ml of rhodamine-conjugated concanavalin A. 
For the QDM-Cys-MCa-Abu complex, 50 nM of 
the complex was incubated with CHO cells for 2 
hrs, and the nuclei stained with 1 µg/ml DHE for 
20 min. For the doxorubicin-linker-Cys-MCa-Abu 
complex, 3 µM of the conjugate was incubated 
with MDA-MB-231 for 2 hrs, followed by staining 
of the plasma membrane with 5 μg/ml of FITC-
conjugated concanavalin A for 3 min. In all 
experiments, live cells were immediately analyzed 
by confocal laser scanning microscopy using a 
Leica TCS-SP2. Alexafluor-488 (excitation at 488 
nm), rhodamine and doxorubicin (excitation at 543 
nm), or Cy5 and QDM (excitation at 642 nm) were 
sequentially excited and emission fluorescence 
collected in z-confocal planes of 10-15 nm steps. 
Images were merged in Adobe Photoshop 7.0. 
RESULTS 
Synthesis of disulphide-less analogs of MCa - Fig. 
1A illustrates the three-dimensional solution 
structure of MCa with three disulphide bridges. 
The aim of this study was to design a MCa analog 
for which convenient chemical coupling could be 
performed by using an N-terminal additional 
cysteine residue. As shown, MCa already contains 
six cysteine residues that contribute to the folding 
of the peptide to form an inhibitor cysteine knot 
motif. Adding an additional cysteine residue at the 
N-terminus may significantly change the normal 
folding of the peptide and the classical disulfide 
bridge arrangement (C1-C4, C2-C5, and C3-C6) in an 
unpredicted manner. In turn, this could 
significantly affect the pharmacological activity 
and cell-penetration properties of the resulting 
molecule(s). To facilitate chemical coupling 
strategies of MCa to cargo molecules, we 
investigated the requirement of disulfide bridges 
on MCa’s pharmacology and cell penetration 
properties. Several analogs were synthesized, each 
with an N-terminal biotinylated lysine for easy 
coupling to fluorescent streptavidin molecules (our 
reporter cargo for this study): MCab, intact with the 
native disulfide bridges, MCab–Abu in which we 
replaced all internal cysteine residues by isosteric 
2-aminobutyric acid (Abu, Fig. 1B), and MCab-
Abu E12A, an analog of MCab-Abu in which Glu12 
was replaced by alanyl, a substitution known to 
improve cell penetration efficacy of MCab (9) (Fig. 
1C). We would expect that removing the disulfide 
bridges of MCa might affect its pharmacology 
more than its cell penetration properties for two 
reasons. First, disulfide bridge patterns are known 
to contribute to the pharmacological activity of 
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toxins (20,21). Second, the structural requirements 
for the pharmacological activity of MCa were 
shown to be more stringent than those required for 
cell penetration as probed by alanine scanning of 
MCa (9). Finally, we synthesized MTXb-Abu, a 
biotinylated version of MTX that has no cell 
penetrating properties on its own and that acts on 
voltage-dependent potassium channels (Fig. 1D). 
This peptide, in which we also replaced six internal 
cysteine residues by Abu derivatives, as for the 
MCab-Abu peptide, was used as a negative control 
in cell penetration experiments. 
Removing disulfide bridges in MCa disrupts the 
secondary structure of the peptide – Circular 
dichroism analyses were performed for MCab, 
MCab-Abu, and MCab-Abu E12A (Fig. 2). As 
shown, the spectra for MCab-Abu and MCab-Abu 
E12A differed significantly from MCab indicating 
the alteration of secondary structures of the 
peptides. These observations are coherent with a 
role of disulfide brides in the 
acquisition/stabilization of secondary structures of 
toxins (11). These data clearly indicate that 
blocking disulfide bridge formation in MCa is a 
successful strategy to alter the structure of MCa. 
Cysteine replacement by Abu derivatives produces 
pharmacologically-inert MCa analogues – MCa is 
known to bind to RyR1 from skeletal muscles (2). 
Upon binding, it modifies the conformation of this 
intracellular calcium channel in such a way that it 
favours binding of [3H]-ryanodine to its receptor, 
probably by converting low affinity binding sites 
to high affinity one. The effect of 1 µM MCab on 
[3H]-ryanodine binding to sarcoplasmic reticulum 
(SR) containing RyR1 was confirmed in this study 
(Fig. 3). An average stimulation in binding of 
59.7-fold was measured (n=3). The value of this 
stimulation depends upon the basal level of 
binding and can occasionally be lower, down to 7-
fold (not shown). Importantly, the two analogs in 
which the cysteine residues were replaced by Abu 
derivatives, MCab-Abu and MCab-Abu E12A, had 
no significant effect on [3H]-ryanodine binding 
indicating that the structural impact of these 
substitutions fully blocked the effect of MCa on 
RyR1. Slight reductions in [3H]-ryanodine binding 
were observed although these effects were not 
significant. Higher concentrations of these two 
analogs were also without effect (not shown). The 
E12A substituted analogue thus proved no better 
than MCab-Abu in spite of the fact that a similar 
mutation in the folded MCa has higher affinity for 
RyR1 (9). 
We also investigated the effect of these 
analogs on Ca2+ homeostasis in muscles fibers. The 
effects of the three peptides MCab, MCab-Abu and 
MCab-Abu E12A were tested on the free Ca2+ 
transients elicited by voltage-clamp 
depolarizations in single skeletal muscle fibers 
from mouse. Fig. 4A shows representative Indo-1 
saturation traces obtained in response to pulses 
from -80 mV to +10 mV of 5, 10, 20 and 50 ms 
duration in (from top to bottom) a control fiber, a 
fiber dialyzed with 100 µM MCab, a fiber dialyzed 
with 200 µM MCab-Abu or a fiber dialyzed with 
200 µM MCab-Abu E12A, respectively. These 
high concentrations of peptides were chosen to 
ensure that effective intracellular levels could be 
reached after equilibration (see Methods). As 
previously described (3), MCab produced a 
remarkable change in the time course of the Ca2+ 
transients: it prevented membrane repolarization-
induced complete turn off of SR Ca2+ release, 
resulting in a prolonged elevation of the 
cytoplasmic [Ca2+] after the end of the pulses. This 
was obviously not the case in the two fibers treated 
respectively with MCab-Abu and MCab-Abu 
E12A, for which the Ca2+ transients yielded 
properties very similar to the ones of the control 
fiber. Corresponding mean values for the peak 
Δ[Ca2+] during the pulse, and the final Δ[Ca2+] at 
the time of the end of the record, are presented in 
Fig. 4B,C. For instance, MCab produced a mean 
final Δ[Ca2+] value of 0.164 ± 0.032 (n=4) 
following a pulse of 20 ms, whereas MCab-Abu 
and MCab-Abu E12A produced only values of 
0.019 ± 0.009 (n=9) and 0.016 ± 0.008 (n=11), 
respectively, compared to 0.017 ± 0.007 (n=10) for 
the control condition. There was thus no 
significant difference in the values for the peak 
Δ[Ca2+], and the final Δ[Ca2+] between control 
fibers and fibers treated with either MCab-Abu or 
MCab-Abu E12A clearly demonstrating a complete 
loss of MCa-induced activity on SR Ca2+ release 
for these two compounds. The effect of MCa likely 
results from competition with a physiological 
interaction between the DHP receptors and RyR1 
(3) explaining why such high concentrations are 
required. We conclude that replacement of the 
cysteine in MCa by Abu derivatives produces non-
folded and pharmacologically-inert analogs. 
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Conserved cell penetration properties of disulfide-
less MCa analogues – Biotinylated MCa, MCab, 
favours the efficient penetration of fluorescently-
labelled streptavidine (Strep) (7,9,22), through 
macropinocytosis (23). The cell penetration of 
MCab/Strep complexes involves one or multiple 
steps of attachment to the membrane through 
binding to cell surface glycosaminoglycans and 
negatively charged lipids. The complex can be 
found predominantly in endosomes, leading to a 
punctate cytoplasmic distribution, a pattern that is 
supposedly linked to the nature of the cargo rather 
than the vector itself. Here, we investigated 
whether the disulfide-less analogues of MCab were 
capable of carrying Strep-Cy5 into CHO cells (Fig. 
5A). As shown, 1 µM of Strep-Cy5 alone is unable 
to enter CHO cells. This was true for 100% of the 
cells examined by confocal microscopy (n=200). 
However, when coupled to either MCab, MCab-
Abu or MCab-Abu E12A in a 4 to 1 ratio and 
incubated for 2 hrs with living CHO cells, the 
resulting complexes gave punctate staining. Here 
again, 100% of the cells were positively stained by 
Strep-Cy5 (n=200 for each condition). This 
punctate staining is an indication of endosomal 
distribution further confirming that it may be 
linked to the nature of the cargo rather than the 
vector, since similar distributions are observed for 
the MCa analogs despite the structural changes in 
the vector. In contrast, no cell penetration of Strep-
Cy5 was observed in CHO cells using a 
biotinylated analogue of MTX, MTXb-Abu, a 
voltage-gated K+ channel blocker (Fig. 5B; 0% of 
n=200 cells examined by confocal microscopy). 
This indicates that MCab-Abu is unlikely to 
penetrate non-specifically into cells owing to its 
amphipatic nature. 
 In order to obtain half-maximal 
Penetration Concentration values (PC50) and the 
extent of total penetration of the complex, 
quantification of cell penetration by fluorescence 
activated cell sorting (FACS) was performed. 
Quantification is a way to distinguish the cell 
penetration efficacies of various MCa analogs (9) 
or of various cell lines (23). As shown in Fig. 6, 
after 2 hrs incubation, both MCab-Abu and MCab-
Abu E12A analogs were less effective than MCab 
since the total Strep-Cy5 fluorescence entering 
CHO cells at maximally effective concentration of 
the peptides (10 µM) was reduced on average by 
28% and 59% for MCab-Abu E12A and MCab-
Abu, respectively (Fig. 6). It is of interest that the 
E12A mutant was more effective than the analog 
without mutation. A similar observation was made 
with the folded version of this mutation (9). This 
effect is most likely due to an increase in the basic 
content of the molecule. With regard to PC50 
values, only slight reductions in the efficacies of 
the analogs were observed. In these experiments, 
we measured PC50 values of 669 ± 27 nM for 
MCab/Strep-Cy5 (n=3), 910 ± 51 nM for MCab-
Abu/Strep-Cy5 (n=3) and 1042 ± 89 nM for MCab-
Abu E12A/Strep-Cy5 (n=3). Therefore, in the case 
of disulfide-less analogs, maximal cell penetration 
of Strep-Cy5 could be obtained by only using 
slightly increased peptide concentrations. 
Adding an N-terminal cysteine residue to a 
disulfide-less MCa analog produces a chemically-
competent peptide for the cell penetration of 
various cargoes – Although the use of Strep brings 
proof of concept, it remains a useless cargo for 
many biological applications, especially if it 
concentrates into endosomes. We therefore 
produced a novel disulfide-less analogue of MCa 
in which we simply replaced the N-terminal 
biotinylated lysine by a cysteine residue in order to 
make various chemical coupling strategies possible 
(Cys-MCa-Abu whose sequence is shown in Fig. 
7A). Next, this peptide was coupled to various 
cargoes using several chemistries and investigated 
for its ability to enter cells (Fig. 7B-D). Cys-MCa-
Abu was first coupled to a FITC fluorescent 
peptide containing a C-terminal cysteine residue. 
The coupling consisted in favoring the formation 
of a disulfide bridge among the two peptides. At 1 
µM, this complex entered CHO cells (100% of the 
cells by confocal microscopy, n=200) whereas 
incubation of CHO cells with 1 µM FITC-labeled 
peptide alone resulted in no cell penetration (Fig. 
7B; 0% of n=200 cells observed). The FITC-
peptide complex stained diffusely the cells 
indicating that it reached both the cytoplasm and 
the nucleus either through direct plasma membrane 
translocation or through endosomal escape. Since 
the Strep and FITC complexes distribute 
differently in the cell, it appears that the cargo 
rather than the vector determines the cell 
distribution. Cys-MCa-Abu was also coupled to 
doxorubicin, an anti-tumor drug, which penetrates 
into MDA-MB-231 cells by itself, and 
concentrates in nuclei where it acts on DNA 
replication. The chemical coupling was performed 
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using a cross-linker, allowing a directional 
coupling with the unique amino group of 
doxorubicin and the SH function of the cysteine 
residue of Cys-MCa-Abu. As shown, incubation of 
MDA-MB-231 cells with either 3 µM doxorubicin 
or doxorubicin-linker-Cys-MCa-Abu resulted in 
significantly different cell distributions (Fig. 7C). 
Covalent linkage of doxorubicin with Cys-MCa-
Abu produced a marked cytoplasmic localization, 
also diffuse, in marked contrast to the 
predominantly nuclear distribution of doxorubicin. 
In 96% of the cells examined (n=200), the 
coupling to Cys-MCa-Abu resulted in a 
cytoplasmic distribution of doxorubicin. Finally, 
near-infrared emitting quantum dots from 
Invitrogen, with amine surfaces, were linked to 
Cys-MCa-Abu using maleimide chemistry. 
Maleimide was added to QD yielding QDM, that 
could further be linked to the SH function of the 
Cys residue of Cys-MCa-Abu. Incubation of 50 
nM of QDM-Cys-MCa-Abu with CHO cells 
resulted in cell penetration with a diffuse 
distribution in both the cytoplasm and the nucleus 
(Fig. 7D; 100% of cells observed; n=200). No 
penetration was observed with QDM incubation 
alone (0% of cells, n=200). The rather efficient 
penetration observed with such a low 
concentration of QDM-Cys-MCa-Abu might be 
explained by the high potential of Cys-MCa-Abu 
grafting at the surface of QDM (about 100 to 120 
maleimide converted functions at the surface of a 
single QD).  
Cell toxicity of MCa analogues – To be considered 
as good cell penetrating vectors, peptides must 
have limited cell toxicity. We investigated 
cerebellar granule cell survival after incubation 
with 10 µM of free vector peptide for 24 hrs (Fig. 
8). This cell system is generally used for the 
evaluation of neuronal survival. It is more stringent 
than the use of cell lines that are more resistant to 
toxic agents. The conditions used in this study 
were deliberately extreme considering the 
conditions required for the cell penetration of our 
vectors. First, incubation times in the range of an 
hour are largely sufficient; second, cell penetration 
is observed at lower concentrations than 10 µM; 
and third, we have evidence suggesting that 
intracellular concentrations of cell penetrating 
peptides increase markedly when cells are 
incubated with the vector alone rather than in 
complex with the cargo. Nevertheless, the 
experimental conditions used here indicate that 
only one of the analog had a significant effect on 
neuronal survival (MCab-Abu, mean survival of 
74.3 ± 4.9%, n=6), whereas all other analogs were 
without significant effects despite of the conditions 
used here (n=6 for each condition). 
 
CONCLUDING REMARKS 
 
By simple substitution of the six cysteine residues 
of MCa, we have produced a series of analogs that 
are devoid of secondary structure and therefore of 
pharmacological activity. These analogs 
nevertheless possess cell-penetrating properties 
that are closely related to those established for 
native MCa. This finding indicates that the proper 
folding of MCa is not essential for the membrane 
translocation. Similarly, the spatial separation of a 
basic face and a hydrophobic face of MCa seems 
of little importance for cell penetration. It cannot 
be excluded however that during the translocation 
process itself, when the peptide interacts with 
negatively charged lipids, it may adopt a 
conformation close to that of native MCa. The 
observation that MTXb-Abu, used as a negative 
control, does not penetrate cells indicates that 
MCa-Abu does not act as a detergent by means of 
its amphipathic nature. Slight increase in effective 
concentrations or reductions in total transport 
capacities of these analogs barely counterbalance 
the benefits of the loss of pharmacological effects 
or the ability to graft an extra-N-terminal cysteine 
residue to the sequence for versatile cargo coupling 
strategies. Our results further indicate that the Cys-
MCa-Abu vector is valuable for the cell delivery of 
a variety of cargoes. The cytoplasmic localization 
of the delivered cargoes using this vector should be 
invaluable for many biological applications for 
which targeting to this compartment are an 
absolute requirement. For future applications, it 
might be recommended to assess the cell toxicity 
of the vector/cargo complexes of interest in the 
conditions of the application. The benefits of all 
cell penetrating peptides undoubtedly lie in the 
value of penetration/toxicity concentration ratio of 
the formed complexes, a value that needs to be 
determined for each application. 
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FIGURE LEGENDS 
Fig. 1. MCa analogues, MCab-Abu and MCab-Abu E12A. A. Ribbon representation of the 3D solution 
structure of MCa illustrating the positions of the three disulfide bridges C1-C4, C2-C5 and C3-C6. S-S bonds 
are shown in blue. The positions of positively charged lysines, essential for cell penetration, are shown in 
red. B. Differences in side chain between cysteine residues and 2-aminobutyric acid (Abu) used for 
substitution of all cysteine residues in MCa amino acid sequence. C. Amino acid sequences of three 
different MCa analogs used in this study. A fourth analog is shown in Fig. 7A. D. Amino acid sequence of 
MTXb-Abu, an analog of MTX in which all cysteine residues are replaced by Abu, and an extra 
biotinylated lysine residue added at the N-terminus. Note that MTX contains six basic amino acid residues 
in its sequence. 
Fig. 2. Determination of the secondary structures of MCab, MCab-Abu and MCab-Abu E12A by circular 
dichroism. Each spectrum presented is the mean of three independent acquisitions taken at a concentration 
of 50 µM in pure water at 20°C. 
Fig. 3. Effect of 1 µM MCab, MCab-Abu or MCab-Abu E12A on [3H]-ryanodine binding onto heavy SR 
vesicles. Specific [3H]-ryanodine binding was measured as described under Materials and Methods. 
Control binding has been performed in the absence of MCa analog. ***, p ≤ 0.01. Note the loss of effect 
upon cysteine replacement by Abu derivatives. The experiment was repeated three times with similar 
results. 
Fig. 4. Effects of MCab, MCab-Abu and MCab-Abu E12A on voltage-activated sarcoplasmic reticulum 
Ca2+ release. A. Indo-1 Ca2+ records in response to membrane depolarizations of increasing duration in a 
control fiber and in fibers dialyzed, respectively, with MCab (100 µM), MCab-Abu (200 µM) and MCab-
Abu E12A (200 µM). B, C. Corresponding mean values for peak Δ[Ca2+], and final Δ[Ca2+] at the end of 
the record in control fibers (n=11) and in fibers dialyzed with either MCab (n=3), MCab-Abu (n=10) or 
MCab-Abu E12A (n=3). Note the loss of pharmacological consequences of replacing cysteine by Abu 
derivatives. 
Fig. 5. Distribution of MCab/, MCab-Abu/ and MCab-Abu E12A/Strep-Cy5 in CHO cells. A. Confocal 
images showing the cell penetration of Strep-Cy5 (2 hrs incubation) in the absence or presence of 4 µM 
MCab, MCab-Abu or MCab-Abu E12A in CHO cells. Colors: blue (Strep-Cy5), red (nuclei, DHE) and 
green (plasma membrane, concanavalin A). Note the lack of differences in cell distribution between Strep-
Cy5 and the MCa analogues used. The punctate distribution is linked to the use of streptavidin as cargo. 
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Scale bars: 10 µm. B. Confocal image of CHO cells showing that 4 µM MTXb-Abu is unable to deliver 
Strep-Cy5 inside cells (2 hrs incubation). Color code as in A. Scale bar: 15 µm. 
Fig. 6. Mean cell fluorescence intensities (MFI) as a function of the concentration of cell penetrating 
complexes for each MCa analog. Indicated concentrations are for Strep-Cy5 (10 nM to 2.5 µM). The ratio 
MCa analog / Strep-Cy5 was 4/1. Data were fitted by a sigmoid equation of the type MFI = MFImax / (1 + 
exp(-(x-PC50)/b)) where MFImax = 180 ± 6 a.u. (MCab), 73 ± 4 a.u. (MCab-Abu) and 129 ± 8 a.u. (MCab-
Abu E12A), b = 200 ± 18 (MCab), 301 ± 38 (MCab-Abu) and 344 ± 64 (MCab-Abu E12A), and half-
penetration concentration values PC50 = 669 ± 27 nM (MCab), 910 ± 51 nM (MCab-Abu) and 1042 ± 89 
nM (MCab-Abu E12A). a.u.: arbitrary units. The MFI values are obtained from a fit of the FACS 
histograms (n=10,000 events in each case). Representative example of n=3 experiments. Experiments 
could not be averaged because the different photomultiplier settings were not calibrated. 
Fig. 7. Design of a cell-penetrating analog for the efficient coupling and delivery of a variety of cargoes. 
A. primary amino acid sequence of the Cys-MCa-Abu analog. This analogue is identical to MCab-Abu 
except that the N-terminal K(biot) has been replaced by an N-terminal cysteine residue. B. Cell 
penetration of FITC-Gpep-Cys when covalently linked to Cys-MCa-Abu (right panel, 1 µM concentration, 
2 hrs incubation with CHO cells). No penetration is observed for 1 µM FITC-Gpep-Cys alone (left panel). 
Code colors: red, concanavalin-A-rhodamine, and green, FITC label. C. Cell penetration of 3 µM 
doxorubicin or the covalently linked complex, doxorubicin-linker-Cys-MCa-Abu, in MDA-MB-231 cells. 
Note that doxorubicin alone goes to the nucleus (red, left panel), whereas coupled to Cys-MCa-Abu it 
concentrates in the cytoplasm. Green: concanavalin-A-FITC for plasma membrane staining. D. Cell 
penetration of 50 nM quantum dots (QD) alone (left panel) or coupled after maleimide modification of 
QDs to Cys-MCa-Abu in CHO cells (right panel). Code colors: red, nuclei (DHE) and blue, QDs. From B 
to D, note the diffuse cytoplasmic staining of the cargoes when coupled to Cys-MCa-Abu. 
Fig. 8. Neuronal toxicity of MCa analogues. Neuronal survival after 24 hrs incubation with 10 µM of each 
MCa analogue was assessed with the MTT assay. No significant differences in neuronal survival were 
observed between the analogues. ***, survival affected with mean + 3 S.D. < 100%. Average of 6 data 
points. 
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